TABLE 2.
Demographic and laboratory findings of the study cohort.
n = 40 | |
Age (y.o.; med ± 5–95 percentile) | 39.9 (23.6–63.8) |
Sex-ratio M/F | 23/17 |
Symptomatic at diagnosis | 92,5 (37/40) |
Virus load at diagnosis (Ct; med ± 5–95 percentile) | 25.9 (20.0–34.9) |
Risk factors [n (%)] | 16/40 (40%) |
>70 y.o. | 1 (2.5%) |
CV disease | 3 (7.5%) |
Active smokers | 6 (15.0%) |
Diabetes | 3 (7.5%) |
Chronic lung disease | 2 (5.0%) |
End-stage renal disease | 0 |
Cancer | 0 |
Secondary ID | 3 (7.5%) |
Cirrhosis | 0 |
BMI > 40 | 0 |
Outcome [n (%)] | |
Hospitalized | 4 (10.0%) |
ARDS | 2 (5.0%) |
ICU | 1 (2.5%) |
Death | 0 |
ARDS, acute respiratory distress syndrome; BMI, body Mass Index; CV, cardiovascular; Ct, cycle threshold; ICU, intensive Care Unit; ID, immunodepression; y.o., years old.